SCHEMBL12379440

SCHEMBL12379440

COC(=O)C1CC2C3CCc4cc(OCc5ccccc5)ccc4C3CC[C@]2(C)C1=O

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.63
USP2 O75604 1/20 0.63
MAPK1 P28482 1/20 0.63
HRH3 Q9Y5N1 1/20 0.55
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
HSD17B1 P14061 7/20 0.53
STS P08842 4/20 0.53
CYP3A4 P08684 1/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1B1 Q16678 1/20 0.51
AKR1C3 P42330 1/20 0.50
LMNA P02545 1/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2292483 1.00 MAPT (0.63) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL12418333 0.88 HSD17B1 (0.63) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL12379505 0.87 USP2 (0.64) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL1977073 0.85 MAPT (0.64) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL7518036 0.85 MAPT (0.63) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL2291598 0.85 HSD17B1 (0.68) MAPTMAPK1HSD17B1STSCYP3A4
SCHEMBL12379386 0.85 HSD17B1 (0.68) MAPTMAPK1HSD17B1STSCYP3A4
SCHEMBL12379510 0.84 HSD17B1 (0.76) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL1979069 0.83 USP2 (0.76) MAPTUSP2MAPK1HRH3KDM4E
SCHEMBL12379442 0.83 USP2 (0.76) MAPTUSP2MAPK1HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed